NuroPro(R), The First Blood Serum Diagnostic Test
 

Power3 Medical Announces Better Than Expected Results for Early Stage Diagnosis Capability of the NuroPro(R) PD Test for Parkinson's Disease

Interim Results From Clinical Validation Trials Underway in Greece and the U.S.

By: , Marketwire,May. 18, 2009 08:45 AM
http://uk.sys-con.com/node/966766

HOUSTON, TX -- (Marketwire) -- 05/18/09 -- Power3 Medical Products, Inc. (OTCBB: PWRM), announced today that results for the early stage diagnosis from clinical validation trials of the NuroPro® PD test for Parkinson's disease are better than expected. The NuroPro PD test was developed to help clinicians distinguish patients with Parkinson's disease from "normal" individuals and patients with other neurological disorders. The NuroPro PD test, developed by Power3, utilizes a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability that a patient has Parkinson's disease. The test is intended to solve a critical challenge facing physicians, clinicians, and patients for a quick, early stage and accurate diagnosis of the debilitating disease known as Parkinson's.

NuroPro(R), The First Blood Serum Diagnostic Test To Be Available For Alzheimer's Disease, Demonstrates High Sensitivity And Specificity

Medical News Today, Article Date: 18 Aug 2008 - 2:00 PDT
http://www.medicalnewstoday.com/articles/118494.php

Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company specializing in the development and commercialization of diagnostic tests for early detection of breast cancer and neurodegenerative diseases, is providing an interim status report of its international validation study of the company's NuroPro® blood serum biomarker test for Alzheimer's disease.

Power3 is currently conducting a 300-patient clinical validation study of its NuroPro® blood serum test for Alzheimer's and Parkinson's disease in collaboration with Dr. Marwan Sabbagh, the Director of Clinical Research at the Cleo Roberts Center of Clinical Research at the Sun Health Research Institute in Sun City, Arizona.